Physician profile
Tobin Thomas
NPI 1891022802
$1,456.31
in general payments reported to CMS, 2019-2025
11 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2022: $340 · 2023: $107 · 2024: $413 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $342.11 | 2022-2023 | |
| Aroa Biosurgery Incorporated | $273.85 | 2024 | |
| Lifenet Health | $153.94 | 2025 | Theragenesis Wound Matrix |
| Integra Lifesciences Corporation | $152.23 | 2021 | |
| Smith+Nephew, INC. | $120.46 | 2021-2025 | Collagenase Santyl, Regranex |
| Organogenesis INC. | $115.26 | 2021 | |
| Melinta Therapeutics, LLC | $114.82 | 2024 | Kimyrsa |
| Tactile Systems Technology INC | $86.92 | 2021 | |
| Hartmann USA, INC. | $52.41 | 2021-2022 | |
| Solventum Corporation | $23.95 | 2024 | Activ.A.C. |
| Hydrofera LLC | $20.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tobin Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.